shutterstock-178045262-web
Stefan Holm / Shutterstock.com
14 August 2014Americas

Federal Circuit refuses to review Dolly the sheep ruling

The US Court of Appeals for the Federal Circuit has refused to grant an en banc review of its ruling that cloned animals made by methods that produced Dolly the sheep cannot be patented, according to Law360.

In May, the Federal Circuit affirmed a decision by the US Patent Trial and Appeal Board (PTAB), finding that while the method for creating a genetic clone can be patent protected, the clones themselves may not, as they do not have “markedly different characteristics from any found in nature”.

The patent examiner had rejected claims in the patent in 2008, finding them to be “anticipated and obvious”, which the PTAB later affirmed.

The named assignee of the patent application at suit, the Edinburgh-based Roslin Institute, said that it was not in a position to comment.


More on this story

Americas
30 May 2014   With the Federal Circuit relying on the precedent set by the Prometheus and Myriad decisions, Dolly the sheep has been summarily declared ineligible for patent protection. Nabeela Rasheed sums up the implications.
Americas
12 May 2014   The US Court of Appeals for the Federal Circuit has ruled that mammals made using the cloning method that created Dolly the sheep are not patent eligible.

More on this story

Americas
30 May 2014   With the Federal Circuit relying on the precedent set by the Prometheus and Myriad decisions, Dolly the sheep has been summarily declared ineligible for patent protection. Nabeela Rasheed sums up the implications.
Americas
12 May 2014   The US Court of Appeals for the Federal Circuit has ruled that mammals made using the cloning method that created Dolly the sheep are not patent eligible.